PAHC vs HBT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PAHC · Phibro Animal Health$32.96 ▼ 6.89%
HBT · HBT Financial$37.00 ▼ 0.32%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PAHC -27.2%
- HBT +58.6%
Head to head
| Metric | PAHC | HBT |
|---|---|---|
| Price | $32.96 | $37.00 |
| Change today | ▼ 6.89% | ▼ 0.32% |
| Market cap | $1.34B | $1.35B |
| Return, 3 months | -3.2% | +3.7% |
| Return, year to date | -10.9% | +46.5% |
| Return, 1 year | -23.7% | +57.7% |
| P/E (TTM) | 13.2 | 14.3 |
| P/B | 3.2 | 1.8 |
| P/E percentile vs own 5y | 33rd | 93rd |
| Dividend yield | 1.46% | 2.49% |
| Revenue growth (YoY, latest qtr) | +4.8% | +40.9% |
| Net profit growth (YoY) | +26.0% | +58.8% |
| Gross margin | 33.8% | – |
| Operating margin | 12.8% | – |
| Net margin | 6.6% | 30.7% |
| Return on equity | 29.7% | 13.2% |
| Analyst target vs. price | +36.5% | +9.9% |
| Analyst buy share | 50% | 33% |
| RSI (14) | 33 | 55 |
| 30-day volatility | 50.1% | 22.4% |
| Max drawdown, 1 year | -52.1% | -12.0% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- HBT is the largest of the group by market value.
- HBT has returned the most over the past year.
- PAHC carries the lowest trailing P/E.
- HBT pays the highest dividend yield.
- HBT is growing revenue fastest.
- HBT keeps the most profit per dollar of sales.
- HBT has been the calmest stock over the last 30 days.